Viviana Escobar
Nurse Practitioner · Miami, FLNPI 1164762712
Payments from drug & device makers
Across 416 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Boehringer Ingelheim$1K
- Amgen$590
- Genentech USA, Inc.$382
- Insmed, Inc.$338
- plus $1K from 17 others
What the payments were for
- Food & beverage$9,037100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 101 | $2,847 |
| GSK | 103 | $2,040 |
| Boehringer Ingelheim | 75 | $1,357 |
| Amgen | 29 | $590 |
| Genentech USA, Inc. | 30 | $382 |
| Insmed, Inc. | 14 | $338 |
| Verona Pharma, Inc. | 16 | $319 |
| Sanofi | 13 | $318 |
| Baxter Healthcare | 7 | $136 |
| Mylan Specialty L.p. | 4 | $125 |
| Fisher & Paykel Healthcare Inc | 3 | $116 |
| Philips North America LLC | 6 | $107 |
| Mallinckrodt Hospital Products Inc. | 3 | $72 |
| United Therapeutics Corporation | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Boston Scientific | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Corium, LLC | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Electromed, Inc. | 1 | $22 |
| Liquidia Technologies, Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,054 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 156 | $129,057 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 48 | $30,480 |
| Breo ElliptaFluticasone/Vilanterol | 59 | $27,472 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 23 | $14,865 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 34 | $14,748 |
| Spiriva RespimatTiotropium Bromide | 28 | $14,173 |
| Incruse ElliptaUmeclidinium Bromide | 18 | $9,399 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $7,431 |
| Spiriva HandihalerTiotropium Bromide | 14 | $7,013 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 50 | $6,215 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 24 | $5,874 |
| Advair DiskusFluticasone Propion/Salmeterol | 21 | $4,166 |
| BreynaBudesonide/Formoterol Fumarate | 18 | $3,961 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 137 | $3,493 |
| Fluticasone Propionate | 135 | $3,181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $2,040 | $180,676267 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,847 | $37,91179 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $1,357 | $29,03851 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Miami
- Margarita FernandezMiami$311K
- Maya BloombergMiami$202K
- Haydee KapinMiami$97K
- Terri PollackMiami$59K
- Amber FederizoMiami$39K
- Patricia Novoa-VogtMiami$35K
- Moriane JosephMiami$23K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.